BRPI1008422A2 - composição farmacêutica sólida, processo de preparação de uma composição farmacêutica sólida, e, composto polimórfico - Google Patents

composição farmacêutica sólida, processo de preparação de uma composição farmacêutica sólida, e, composto polimórfico

Info

Publication number
BRPI1008422A2
BRPI1008422A2 BRPI1008422A BRPI1008422A BRPI1008422A2 BR PI1008422 A2 BRPI1008422 A2 BR PI1008422A2 BR PI1008422 A BRPI1008422 A BR PI1008422A BR PI1008422 A BRPI1008422 A BR PI1008422A BR PI1008422 A2 BRPI1008422 A2 BR PI1008422A2
Authority
BR
Brazil
Prior art keywords
pharmaceutical composition
solid pharmaceutical
preparing
polymorphic compound
polymorphic
Prior art date
Application number
BRPI1008422A
Other languages
English (en)
Inventor
Alain Rolland
Anne Brochard
Barry Victor Lloyd Potter
Bertrand Poirot
Chistian Diolez
Damien Martins
Delphine Delahaye
Francis Diancourt
Gérard Coquerel
JOëL RICHARD
Julie Linol
Lok Wai Lawrence Woo
Marie-Noêlle Petit
Nathalie Mondoly
Ophélie Houssin
Original Assignee
Ipsen Pharma Sas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR0900656A external-priority patent/FR2942226B1/fr
Priority claimed from FR0900655A external-priority patent/FR2942225B1/fr
Application filed by Ipsen Pharma Sas filed Critical Ipsen Pharma Sas
Publication of BRPI1008422A2 publication Critical patent/BRPI1008422A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/78—Ring systems having three or more relevant rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
    • A61K31/37—Coumarins, e.g. psoralen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/94—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems condensed with rings other than six-membered or with ring systems containing such rings
BRPI1008422A 2009-02-13 2010-02-12 composição farmacêutica sólida, processo de preparação de uma composição farmacêutica sólida, e, composto polimórfico BRPI1008422A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0900656A FR2942226B1 (fr) 2009-02-13 2009-02-13 Nouveau polymorphe cristallin du 6-oxo+6,7,8,9,10,11-hexahydrocyclohepta°c!chromen-3-yl sulfamate
FR0900655A FR2942225B1 (fr) 2009-02-13 2009-02-13 Variete i du 6-oxo-6,7,8,9,10,11-hexahydroclyclohepta5°c!chromen-3 yl sulfamate de granulometrie reduite
PCT/FR2010/000117 WO2010092260A2 (fr) 2009-02-13 2010-02-12 Compositions pharmaceutiques du 6-oxo-6.7.8,9.10.11-hexahydrocyclohepta mchromen-3-yl sulfamate

Publications (1)

Publication Number Publication Date
BRPI1008422A2 true BRPI1008422A2 (pt) 2016-03-01

Family

ID=42562120

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI1008422A BRPI1008422A2 (pt) 2009-02-13 2010-02-12 composição farmacêutica sólida, processo de preparação de uma composição farmacêutica sólida, e, composto polimórfico

Country Status (10)

Country Link
EP (1) EP2396311A2 (pt)
JP (1) JP2012517988A (pt)
KR (1) KR20110115607A (pt)
CN (1) CN102317276A (pt)
AU (1) AU2010212753A1 (pt)
BR (1) BRPI1008422A2 (pt)
CA (1) CA2751393A1 (pt)
MX (1) MX2011008239A (pt)
RU (1) RU2011137516A (pt)
WO (1) WO2010092260A2 (pt)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3592338A1 (en) * 2017-03-08 2020-01-15 ARIAD Pharmaceuticals, Inc. Pharmaceutical formulations comprising 5-chloro-n4

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9603325D0 (en) * 1996-02-16 1996-04-17 Imperial College A compound
US6921776B1 (en) * 1996-02-16 2005-07-26 Sterix Limited Compound
CN1309387C (zh) * 2003-04-15 2007-04-11 南昌弘益科技有限公司 溶出度得到提高的甲芬那酸分散片及其制备方法—镇痛、解热、抗炎药
GB0408308D0 (en) * 2004-04-14 2004-05-19 Vectura Ltd Pharmaceutical compositions
GB0511190D0 (en) * 2005-06-01 2005-07-06 Sterix Ltd Use
AU2007325628A1 (en) * 2006-11-28 2008-06-05 Marinus Pharmaceuticals Nanoparticulate formulations and methods for the making and use thereof

Also Published As

Publication number Publication date
WO2010092260A8 (fr) 2011-08-11
CN102317276A (zh) 2012-01-11
WO2010092260A3 (fr) 2011-02-17
CA2751393A1 (fr) 2010-08-19
EP2396311A2 (fr) 2011-12-21
JP2012517988A (ja) 2012-08-09
RU2011137516A (ru) 2013-03-20
MX2011008239A (es) 2011-09-06
AU2010212753A1 (en) 2011-09-01
KR20110115607A (ko) 2011-10-21
WO2010092260A2 (fr) 2010-08-19

Similar Documents

Publication Publication Date Title
BRPI0905717A2 (pt) Composição farmacêutica, processo para preparar uma composição farmacêutica e forma de dosagem farmacêutica
BRPI1011764A2 (pt) composição farmacêutica, e, método para preparar uma composição farmacêutica
BRPI0911254A2 (pt) processo para a preparação de um composto
BRPI0916712A2 (pt) processo para preparar uma composição detergente
BRPI0909691A8 (pt) composto, método para preparar um composto, e, composição farmacêutica
BRPI0912384A2 (pt) composição, e, método para preparar uma composição
BR112012016912A2 (pt) composição de gel de diagnóstico, método para preparar uma composição de gel de diagnóstico
BRPI1007161A2 (pt) composição farmacêutica oral, e processo para preparar uma composição
BRPI1012018A2 (pt) processo para preparar um composto
BR112013008008A2 (pt) composto, composição farmacêutica e processo para preparar um composto
BRPI0910545A2 (pt) processo contínuo para fazer composições farmacêuticas
PL2311970T3 (pl) Sposób wytwarzania bioproduktów
BRPI0914674A2 (pt) processo para preparação de um pó
BRPI1011888A2 (pt) processo para preparar um composto, e, composição.
BRPI1007654A2 (pt) composto, processo para a obtenção de um composto de fórmula geral e composição farmacêutica
BRPI0921420A2 (pt) processo para preparar compostos
BRPI0820644A2 (pt) método de preparação de uma composição, e, composição
BR112012000258A2 (pt) processo para preparar uma alquenona.
BRPI1016109A2 (pt) "composto, composição farmacêutica, e, processo para preparar um composto"
BRPI0911992A2 (pt) processo para preparação de bifenilanilidas substituídas
BR112013005986A2 (pt) processo para preparar uma composição derivada de estolídeo e composição derivada de estolídeo
BRPI0811548A2 (pt) Forma polimórfica de um composto, composição farmacêutica, e, processo para sintetizar uma forma polimórfica de um composto
IL206266A0 (en) Process for recovering florfenicol from pharmaceutical compositions
BR112012002130A2 (pt) processo para a preparação de composto,e, composto intermediário
BRPI0821752A2 (pt) Processo para preparar derivados de ácido 22-fluoracil-3-amino-acrílico

Legal Events

Date Code Title Description
B08F Application fees: application dismissed [chapter 8.6 patent gazette]

Free format text: REFERENTE A 6A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2383 DE 06-09-2016 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.

B350 Update of information on the portal [chapter 15.35 patent gazette]